Stopping PPI Therapy in Inactive IBD

Abroad (travel likely)RecruitingPHASE4

Conditions

Ulcerative Colitis (UC) · Crohn's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Nottingham, Nottingham, United Kingdom
Contact: Study coordinator (Gordon W Moran, MD, PhD) · Gordon.moran@nottingham.ac.uk · 0115 9249924

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Ulcerative Colitis (UC) · Crohn's Disease (CD) · Indeterminate Colitis

Abroad (travel likely)Recruiting

New Haven, United States · Iowa City, United States

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Ulcerative Colitis · Ulcerative Colitis Chronic · Inflammatory Bowel Diseases

IsraelRecruitingPHASE3

San Francisco, United States · Hartford, United States

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Ulcerative Colitis · Crohn's Disease

IsraelRecruitingPHASE3

Mobile, United States · Phoenix, United States

De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis

Crohn Disease (CD) · Ulcerative Colitis (UC)

Abroad (travel likely)RecruitingPHASE4

Montreal, Canada